Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 26:9:972586.
doi: 10.3389/fmed.2022.972586. eCollection 2022.

Peripheral vitamin D levels in ankylosing spondylitis: A systematic review and meta-analysis

Maohui Diao  1 , Jun Peng  1 , Daidong Wang  1 , Hongbo Wang  1
Affiliations

Peripheral vitamin D levels in ankylosing spondylitis: A systematic review and meta-analysis

Maohui Diao et al. Front Med (Lausanne). .

Abstract

Objectives: Previous studies showed conflicting results regarding peripheral vitamin D levels in ankylosing spondylitis (AS). We performed this systemic review and meta-analysis to explore whether vitamin D may influence AS process.

Methods: Articles published until March 2022 were searched in databases as follows: PubMed, Web of Science, and Google Scholar. The present study included cross-sectional and case-control studies regarding vitamin D levels in patients with AS. Studies were excluded according to the following exclusion criteria: (1) we excluded studies which did not provide sufficient information regarding the comparison of vitamin D levels in AS patients and healthy controls (HC). Vitamin D levels in the two group studies should be reported or could be calculated in included studies; (2) meta-analysis, reviews and case reports. STATA 12.0 software was used to make a meta-analysis. Standard mean differences (SMDs) and 95% confidence intervals (CIs) were computed as effect size.

Results: The present meta-analysis showed no significant difference in peripheral 1,25-dihydroxyvitamin D3 (1,25OHD) levels between AS and healthy controls (HCs) in Caucasians with a random effects model [SMD: -0.68, 95% CI (-1.90, 0.54)]. Patients with AS had lower peripheral 25-hydroxyvitamin D (25OHD) levels compared with HC with a random effects model [SMD: -0.45, 95% CI: (-0.70, -0.20)]. Patients with AS had higher peripheral C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) levels compared with HC in Caucasian population with random effects models [CRP: SMD: 1.08, 95% CI: (0.78, 1.37); ESR: SMD: 0.86, 95% CI: (0.39, 1.34)]. However, no significant difference in alkaline phosphatase (ALP), parathyroid hormone (PTH) or calcium levels were indicated between AS and HC in Caucasian with random effects models [ALP: SMD: 0.07, 95% CI: (-0.41, 0.55); PTH: SMD: -0.15, 95% CI: (-0.56, 0.26); calcium: SMD: -0.06, 95% CI: (-0.39, 0.26)].

Conclusion: In conclusion, the study showed an inverse association between 25OHD and AS, which suggests that vitamin D may have a protective effect on AS. ESR and C-reactive protein (CRP) are important biomarkers for AS.

Keywords: 1; 25-dihydroxyvitamin D3; ankylosing spondylitis; meta-analysis; systematic review; vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Forest plot regarding comparison in peripheral 1,25OHD levels between AS and HC. AS, ankylosing spondylitis; HC, healthy controls; 1,25OHD, 1,25-dihydroxyvitamin D3.
Figure 2
Figure 2
Forest plot regarding comparison in peripheral 25OHD levels between AS and HC. AS, ankylosing spondylitis; HC, healthy controls; 25OHD, 25-hydroxyvitamin D.
Figure 3
Figure 3
Forest plot regarding comparison in peripheral ALP levels between AS and HC. ALP, alkaline phosphatase; AS, ankylosing spondylitis; HC, healthy controls.
Figure 4
Figure 4
Forest plot regarding comparison in peripheral CRP levels between AS and HC. AS, ankylosing spondylitis; CRP, C-reactive protein; HC, healthy controls.
Figure 5
Figure 5
Forest plot regarding comparison in peripheral ESR levels between AS and HC. AS, ankylosing spondylitis; ESR, erythrocyte sedimentation rate; HC, healthy controls.
Figure 6
Figure 6
Forest plot regarding comparison in peripheral PTH levels between AS and HC. AS, ankylosing spondylitis; HC, healthy controls; PTH, parathyroid hormone.
Figure 7
Figure 7
Forest plot regarding comparison in peripheral calcium levels between AS and HC. AS, ankylosing spondylitis; HC, healthy controls.
See this image and copyright information in PMC

References

    1. Wenker KJ, Quint JM. Ankylosing Spondylitis. Treasure Island, FL: StatPearls Publishing LLC. (2021). - PubMed
    1. Liang H, Xu L, Tian X, Wang S, Liu X, Dai Y, et al. The comparative efficacy of supervised- versus home-based exercise programs in patients with ankylosing spondylitis: a meta-analysis. Medicine. (2020) 99:e19229. 10.1097/MD.0000000000019229 - DOI - PMC - PubMed
    1. Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ. Global prevalence of ankylosing spondylitis. Rheumatology. (2014) 53:650–7. 10.1093/rheumatology/ket387 - DOI - PubMed
    1. Simone D, Al Mossawi MH, Bowness P. Progress in our understanding of the pathogenesis of ankylosing spondylitis. Rheumatology. (2018) 57:vi4–9. 10.1093/rheumatology/key001 - DOI - PMC - PubMed
    1. Voruganti A, Bowness P. New developments in our understanding of ankylosing spondylitis pathogenesis. Immunology. (2020) 161:94–102. 10.1111/imm.13242 - DOI - PMC - PubMed

Publication types